Literature DB >> 2582051

Identification of herpes simplex virus type 1 (HSV-1) glycoprotein gC as the immunodominant antigen for HSV-1-specific memory cytotoxic T lymphocytes.

J Glorioso, U Kees, G Kümel, H Kirchner, P H Krammer.   

Abstract

The frequency and fine specificity of herpes simplex virus (HSV)-reactive cytotoxic T lymphocytes (CTL) of C57BL/6 mice was investigated in limiting dilution culture. The reactivity patterns of virus-specific CTL were assayed on target cells infected with HSV type 1, strain KOS, HSV type 2, strain Mueller, and mutants of HSV-1 (KOS) antigenically deficient or altered in glycoproteins gC or gB, two of the four major HSV-1-encoded cell surface glycoprotein antigens. Most CTL clones recognized type-specific determinants on target cells infected with the immunizing HSV serotype. In addition, the majority of HSV-1-specific CTL did not cross-react with cells infected with syn LD70, a mutant of HSV-1 (KOS) deficient for the presentation of cell surface glycoprotein gC. These data are the first demonstration of the clonal specificity of HSV-1-reactive CTL, and they identify gC as the immunodominant antigen. The fine specificity of gC-specific CTL clones was analyzed on target cells infected with mutant viruses altered in the antigenic structure of gC. These mutants were selected by resistance to neutralization with monoclonal antibodies, referred to as monoclonal antibody-resistant (mar) mutants. Most mar mutations in gC did not affect recognition by the majority of CTL clones. This indicated that most epitopes recognized by CTL are distinct from those defined by antibodies. The finding, however, that one mar mutation in gC affected both CTL and antibody recognition of this antigen may help to define antigenic sites important to both humoral and cell-mediated immunity to herpesvirus infection.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2582051

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  29 in total

1.  Variation in lymphoproliferative responses during recrudescent orofacial herpes simplex virus infections.

Authors:  J P Vestey; M Norval; S Howie; J Maingay; W A Neill
Journal:  Clin Exp Immunol       Date:  1989-09       Impact factor: 4.330

2.  Kinetics of expression of herpes simplex virus type 1-specific glycoprotein species on the surfaces of infected murine, simian, and human cells: flow cytometric analysis.

Authors:  S R Jennings; P A Lippe; K J Pauza; P G Spear; L Pereira; S S Tevethia
Journal:  J Virol       Date:  1987-01       Impact factor: 5.103

3.  Characterization of the antigenic structure of herpes simplex virus type 1 glycoprotein C through DNA sequence analysis of monoclonal antibody-resistant mutants.

Authors:  C T Wu; M Levine; F Homa; S L Highlander; J C Glorioso
Journal:  J Virol       Date:  1990-02       Impact factor: 5.103

4.  Species selective interaction of Alphaherpesvirinae with the "unspecific" immune system of the host.

Authors:  H P Huemer; C Larcher; S van Drunen Littel-van den Hurk; L A Babiuk
Journal:  Arch Virol       Date:  1993       Impact factor: 2.574

5.  Disulfide bond structure determination and biochemical analysis of glycoprotein C from herpes simplex virus.

Authors:  A H Rux; W T Moore; J D Lambris; W R Abrams; C Peng; H M Friedman; G H Cohen; R J Eisenberg
Journal:  J Virol       Date:  1996-08       Impact factor: 5.103

6.  Cells expressing herpes simplex virus glycoprotein gC but not gB, gD, or gE are recognized by murine virus-specific cytotoxic T lymphocytes.

Authors:  K L Rosenthal; J R Smiley; S South; D C Johnson
Journal:  J Virol       Date:  1987-08       Impact factor: 5.103

7.  Expression in recombinant vaccinia virus of the equine herpesvirus 1 gene encoding glycoprotein gp13 and protection of immunized animals.

Authors:  P X Guo; S Goebel; S Davis; M E Perkus; B Languet; P Desmettre; G Allen; E Paoletti
Journal:  J Virol       Date:  1989-10       Impact factor: 5.103

8.  Necrotizing chorioretinitis in mice inoculated with herpes simplex virus type 1 with or without glycoprotein C: anterior chamber-associated immune deviation does not persist.

Authors:  Y Liu; H Minagawa; Y Toh; Y Sakai; T Ishibashi; H Inomata; R Mori
Journal:  Arch Virol       Date:  1993       Impact factor: 2.574

9.  Specificity of human natural killer cells in limiting dilution culture for determinants of herpes simplex virus type 1 glycoproteins.

Authors:  G A Bishop; G Kümel; S A Schwartz; J C Glorioso
Journal:  J Virol       Date:  1986-01       Impact factor: 5.103

10.  Genetic analysis of type-specific antigenic determinants of herpes simplex virus glycoprotein C.

Authors:  K E Dolter; W F Goins; M Levine; J C Glorioso
Journal:  J Virol       Date:  1992-08       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.